Submission Details
| 510(k) Number | K060853 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 29, 2006 |
| Decision Date | June 09, 2006 |
| Days to Decision | 72 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K060853 is an FDA 510(k) clearance for the ONLINE TDM TOBRAMYCIN, a Radioimmunoassay, Tobramycin (Class II — Special Controls, product code KLB), submitted by Roche Diagnostics Corp. (Indianapolos, US). The FDA issued a Cleared decision on June 9, 2006, 72 days after receiving the submission on March 29, 2006. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3900.
| 510(k) Number | K060853 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 29, 2006 |
| Decision Date | June 09, 2006 |
| Days to Decision | 72 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | KLB — Radioimmunoassay, Tobramycin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3900 |